Browse > Article
http://dx.doi.org/10.5483/BMBRep.2020.53.8.031

Bee venom inhibits the proliferation and migration of cervical-cancer cells in an HPV E6/E7-dependent manner  

Kim, Da-Hyun (Department of Biochemistry & Molecular Biology, Yonsei University College of Medicine)
Lee, Hyun-Woo (Department of Biochemistry & Molecular Biology, Yonsei University College of Medicine)
Park, Hyun-Woo (Department of Biochemistry, College of Life Science, Yonsei University)
Lee, Han-Woong (Department of Biochemistry, College of Life Science, Yonsei University)
Chun, Kyung-Hee (Department of Biochemistry & Molecular Biology, Yonsei University College of Medicine)
Publication Information
BMB Reports / v.53, no.8, 2020 , pp. 419-424 More about this Journal
Abstract
Bee venom (BV), secreted from the venom gland of the honey bee, contains several biological active compounds. BV has been widely used as a traditional medicine for treating human disease, including cancer. In this study, we have shown the molecular mechanism underlying the therapeutic effect of BV on cancer. Treatment with BV reduced the proliferation of cervical-cancer cells in a dose- and time-dependent manner. Interestingly, the killing effect of BV was specific to HPV-positive cervical-cancer cell lines, such as Caski and HeLa cells, and not to HPV-negative cervical-cancer cells (C33A). BV reduced the expression of HPV E6 and E7 at RNA and protein levels, leading to an increase in the expression of p53 and Rb in Caski and HeLa cells. Further, BV decreased the levels of cell-cycle proteins, such as cyclin A and B, and increased the levels of cell-cycle inhibitors, such as p21 and p27. BV significantly induced apoptosis and inhibited wound healing and migration of cervical-cancer cells. It also upregulated the expression of pro-apoptotic BAX and downregulated the expression of anti-apoptotic Bcl-2 and Bcl-XL. Cleavage of caspase-3, caspase-9, and PARP were also induced by BV treatment, whereas the phosphorylation of mitogenic signaling-related proteins, such as AKT, JNK, p38, and ERK, were downregulated. Our results indicate that BV has a therapeutic selectivity for HPV-positive malignant cells, so further clinical studies are needed to assess its clinical application.
Keywords
Bee venom; Cervical cancer; Human papillomavirus;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Cuadrado A and Nebreda AR (2010) Mechanisms and functions of p38 MAPK signalling. Biochemical J 429, 403-417   DOI
2 Koul HK and Khandrika L (2008) Signal transduction targets in prostate cancer. Curr Signal Transduct Ther 3, 112-128   DOI
3 Lee HW, Jang KS, Choi HJ, Jo A, Cheong JH and Chun KH (2014) Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy. BMB Rep 47, 697-702   DOI
4 Kang HG, Kim WJ, Kang HG, Chun KH and Kim SJ (2019) Galectin-3 Interacts with C/EBPbeta and Upregulates Hyaluronan-Mediated Motility Receptor Expression in Gastric Cancer. Mol Cancer Res 18, 403-413   DOI
5 Cho Y, Kang HG, Kim SJ et al (2018) Post-translational modification of OCT4 in breast cancer tumorigenesis. Cell Death Differ 25, 1781-1795   DOI
6 Baek JH, Kim NJ, Song JK and Chun KH (2017) Kahweol inhibits lipid accumulation and induces Glucose-uptake through activation of AMP-activated protein kinase (AMPK). BMB Rep 50, 566-571   DOI
7 Kim SJ, Lee HW, Baek JH et al (2016) Activation of nuclear PTEN by inhibition of Notch signaling induces G2/M cell cycle arrest in gastric cancer. Oncogene 35, 251-260   DOI
8 Kim SJ, Choi IJ, Cheong TC et al (2010) Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression. Gastroenterology 138, 1035-1045   DOI
9 Kim NJ, Baek JH, Lee J, Kim H, Song JK and Chun KH (2019) A PDE1 inhibitor reduces adipogenesis in mice via regulation of lipolysis and adipogenic cell signaling. Exp Mol Med 51, 5   DOI
10 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68, 394-424   DOI
11 Hwang LY, Ma Y, Shiboski SC, Farhat S, Jonte J and Moscicki AB (2012) Active squamous metaplasia of the cervical epithelium is associated with subsequent acquisition of human papillomavirus 16 infection among healthy young women. J Infect Dis 206, 504-511   DOI
12 Marth C, Landoni F, Mahner S et al (2017) Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 28, iv72-iv83   DOI
13 Tomao F, Santangelo G, Musacchio L et al (2020) Targeting cervical cancer: Is there a role for poly (ADPribose) polymerase inhibition? J Cell Physiol 6, 5050-5058
14 Chaisakul J, Hodgson WC, Kuruppu S and Prasongsook N (2016) Effects of animal venoms and toxins on hallmarks of cancer. J Cancer 7, 1571-1578   DOI
15 Hossen MS, Shapla UM, Gan SH and Khalil MI (2017) Impact of bee venom enzymes on diseases and immune responses. Molecules 22, 25   DOI
16 Yao YL, Tian QF, Cheng B, Cheng YF, Ye J and Lu WG (2017) Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women. J Zhejiang Univ Sci B 18, 256-262
17 Kim YS, Jun H, Chae Y et al (2005) The practice of Korean medicine: An overview of clinical trials in acupuncture. Evid Based Complement Alternat Med 2, 325-352   DOI
18 Kim YW, Chaturvedi PK, Chun SN, Lee YG and Ahn WS (2015) Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line. Oncol Rep 33, 1675-1682   DOI
19 Walboomers JMM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189, 12-19   DOI
20 Cyprian FS, Al-Farsi HF, Vranic S, Akhtar S and Al Moustafa AE (2018) Epstein-Barr virus and human papillomaviruses interactions and their roles in the initiation of epithelialmesenchymal transition and cancer progression. Front Oncol 8, 111   DOI
21 Orsolic N (2012) Bee venom in cancer therapy. Cancer Metastasis Rev 31, 173-194   DOI
22 Rady I, Siddiqui IA, Rady M and Mukhtar H (2017) Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett 402, 16-31   DOI
23 Hong JJ, Lu XM, Deng ZX, Xiao SF, Yuan B and Yang K (2019) How melittin inserts into cell membrane: conformational changes, Inter-Peptide Cooperation, and Disturbance on the Membrane. Molecules 24, 1775   DOI
24 Liu SJ, Yu M, He Y et al (2008) Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology 47, 1964-1973   DOI
25 Yim EK and Park JS (2005) The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer Res Treat 37, 319-324   DOI
26 Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296, 1655-1657   DOI
27 Lipari F, McGibbon GA, Wardrop E and Cordingley MG (2001) Purification and biophysical characterization of a minimal functional domain and of an N-terminal Zn2+-binding fragment from the human papillomavirus type 16 E6 protein. Biochemistry 40, 1196-1204   DOI
28 Crook T, Tidy JA and Vousden KH (1991) Degradation of P53 can be targeted by Hpv E6 sequences distinct from those required for P53 binding and transactivation. Cell 67, 547-556   DOI
29 Naseri MH, Mahdavi M, Davoodi J, Tackallou SH, Goudarzvand M and Neishabouri SH (2015) Up regulation of Bax and down regulation of Bcl2 during 3-NC mediated apoptosis in human cancer cells. Cancer Cell Int 15, 55   DOI
30 Sarbassov DD, Ali SM and Sabatini DM (2005) Growing roles for the mTOR pathway. Curr Opin Cell Biol 17, 596-603   DOI
31 Weston CR and Davis RJ (2007) The JNK signal transduction pathway. Curr Opin Cell Biol 19, 142-149   DOI
32 Tournier C, Dong C, Turner TK, Jones SN, Flavell RA and Davis RJ (2001) MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev 15, 1419-1426   DOI
33 Koul HK, Pal M and Koul S (2013) Role of p38 MAP kinase signal transduction in solid tumors. Genes Cancer 4, 342-359   DOI